Johanna Friedl Naderer Dyne Therapeutics, Inc. (DYN) insider trading activity

Johanna Friedl Naderer is Chief Commercial Officer of Dyne Therapeutics, Inc.. Currently has a direct ownership of 94,729 shares of DYN, which is worth approximately $1.78 Million. The most recent transaction as insider was on Dec 05, 2025, when has been sold 144 shares (Common Stock) at a price of $20.72 per share, resulting in proceeds of $2,983. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 94.7K

0.15% 3M change

1.53% 12M change

Total Value Held $1.78 Million

Johanna Friedl-Naderer Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 05 2025	SELL Open market or private sale	$2,983 $20.72 p/Share	144 Reduced 0.15%	94,729 Common Stock
Sep 05 2025	SELL Open market or private sale	$1,931 $13.41 p/Share	144 Reduced 0.15%	94,873 Common Stock
Sep 04 2025	SELL Open market or private sale	$11,863 $13.27 p/Share	894 Reduced 0.93%	95,017 Common Stock
Jun 05 2025	SELL Open market or private sale	$1,949 $13.35 p/Share	146 Reduced 0.15%	95,911 Common Stock
Mar 13 2025	SELL Open market or private sale	$1,733 $12.12 p/Share	143 Reduced 0.15%	96,057 Common Stock
Dec 04 2024	BUY Grant, award, or other acquisition	-	37,800 Added 28.21%	96,200 Common Stock
Sep 03 2024	BUY Grant, award, or other acquisition	-	58,400 Added 50.0%	58,400 Common Stock

Also insider at

VIR

Vir Biotechnology, Inc. Healthcare

EVP & Chief Operating Officer